Public consultation on HIV prevention strategy using PrEP launched by HIQA

A HIV prevention strategy using “a highly effective drug “ would ward off around 173 infections over the first five years of the programme, according to the Health Information and Quality Authority.

A pre-exposure prophylaxis (PrEP) programme would cost €1.5m in the first year and €5.4m over five years and Hiqa estimates that a “break even” point would be reached after 14 years – where all programme and medication costs will have been recouped.